Sagittarius Life Science (3205) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sagittarius Life Science (3205) has a cash flow conversion efficiency ratio of -0.020x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-21.27 Million ≈ $-670.00K USD) by net assets (NT$1.04 Billion ≈ $32.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 3205 equity to assets ratio to measure how much of total assets are equity-financed.
Sagittarius Life Science - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how Sagittarius Life Science's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Sagittarius Life Science cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Sagittarius Life Science Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sagittarius Life Science ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Konya Kagit Sanayi ve Ticaret AS
IS:KONKA
|
-0.023x |
|
Nicola Mining Inc
V:NIM
|
0.542x |
|
Alpha Astika Akinita S.A
AT:ASTAK
|
-0.330x |
|
Leo Systems
TWO:5410
|
0.402x |
|
SYN-Tech Chem & Pharm Co Ltd
TWO:1777
|
0.099x |
|
Marks and Spencer Group PLC
LSE:MKS
|
0.289x |
|
Synergy Green Industries Limited
NSE:SGIL
|
0.056x |
|
Suraj Estate Developers Ltd.
NSE:SURAJEST
|
0.008x |
Annual Cash Flow Conversion Efficiency for Sagittarius Life Science (2015–2025)
The table below shows the annual cash flow conversion efficiency of Sagittarius Life Science from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see 3205 market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$1.04 Billion ≈ $32.92 Million |
NT$-36.05 Million ≈ $-1.14 Million |
-0.035x | +67.44% |
| 2024-12-31 | NT$419.76 Million ≈ $13.22 Million |
NT$-44.48 Million ≈ $-1.40 Million |
-0.106x | +19.51% |
| 2023-12-31 | NT$526.90 Million ≈ $16.60 Million |
NT$-69.37 Million ≈ $-2.19 Million |
-0.132x | -13.36% |
| 2022-12-31 | NT$455.42 Million ≈ $14.35 Million |
NT$-52.89 Million ≈ $-1.67 Million |
-0.116x | -111.62% |
| 2021-12-31 | NT$531.71 Million ≈ $16.75 Million |
NT$-29.18 Million ≈ $-919.36K |
-0.055x | +48.12% |
| 2020-12-31 | NT$588.38 Million ≈ $18.54 Million |
NT$-62.24 Million ≈ $-1.96 Million |
-0.106x | +31.72% |
| 2019-12-31 | NT$674.50 Million ≈ $21.25 Million |
NT$-104.50 Million ≈ $-3.29 Million |
-0.155x | -113.51% |
| 2018-12-31 | NT$797.37 Million ≈ $25.12 Million |
NT$-57.86 Million ≈ $-1.82 Million |
-0.073x | -200.52% |
| 2017-12-31 | NT$965.47 Million ≈ $30.42 Million |
NT$-23.31 Million ≈ $-734.49K |
-0.024x | -108.12% |
| 2016-12-31 | NT$1.21 Billion ≈ $38.18 Million |
NT$360.37 Million ≈ $11.35 Million |
0.297x | -10.68% |
| 2015-12-31 | NT$714.71 Million ≈ $22.52 Million |
NT$237.94 Million ≈ $7.50 Million |
0.333x | -- |
About Sagittarius Life Science
Sagittarius Life Science Corp engages in the research, development, and sale of Chinese and western medicines, and health food products in Taiwan and Asia. It also offers organic food, daily necessities, and pet food; and engages in the research and development of biotechnology. Sagittarius Life Science Corp was founded in 1998 and is based in Taipei, Taiwan.